Search Within

Ronglai Shen

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (5)
Groups
  1. Biostatistics Service (5)
  2. Department of Pathology and Laboratory Medicine (5)
  3. Epidemiology and Biostatistics (5)
  4. GSK Faculty (5)
  5. Molecular Pharmacology and Chemistry Program Faculty (5)
  6. Population Sciences Research Program (5)

More Groups

People
  1. Neal Rosen (3)
  2. Alan Ho (2)
  3. David Hyman (2)
  4. David Solit (2)
  5. Jorge Reis-Filho (2)
  6. Maurizio Scaltriti (2)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2018 (1)
  4. 2015 (1)
  5. 2013 (1)
Publications
  1. Cancer Cell (1)
  2. Cancer Discovery (1)
  3. Frontiers in Immunology (1)
  4. Journal of Clinical Oncology (1)
  5. New England Journal of Medicine (1)
Publishers
  1. American Association for Cancer Research (1)
  2. American Society of Clinical Oncology (1)
  3. Cell Press (1)
  4. Frontiers Media S.A. (1)
  5. Massachusetts Medical Society (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors
    Journal Article

    Cohen, I. J.; Pareja, F.; Socci, N. D.; Shen, R.; Doane, A. S.; Schwartz, J.; Khanin, R.; Morris, E. A.; Sutton, E. J.; Blasberg, R. G.
    Frontiers in Immunology (2022)

    Fulltext@MSK | Save
  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Journal Article

    Li, B. T.; Michelini, F.; Misale, S.; Cocco, E.; Baldino, L.; Cai, Y.; Shifman, S.; Tu, H. Y.; Myers, M. L.; Xu, C.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Loss of the FAT1 tumor suppressor promotes resistance to CDK4/6 inhibitors via the Hippo pathway
    Journal Article

    Li, Z.; Razavi, P.; Li, Q.; Toy, W.; Liu, B.; Ping, C.; Hsieh, W.; Sanchez-Vega, F.; Brown, D. N.; Da Cruz Paula, A. F.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Extreme outlier analysis identifies occult mitogen-activated protein kinase pathway mutations in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Sylvester, B. E.; Won, H.; McDermott, G.; DeLair, D.; Ramirez, R.; Yao, Z.; Shen, R. L.; Dao, F.; Bogomolniy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Journal Article

    Ho, A. L.; Grewal, R. K.; Leboeuf, R.; Sherman, E. J.; Pfister, D. G.; Deandreis, D.; Pentlow, K. S.; Zanzonico, P. B.; Haque, S.; Gavane, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save